Profile
Shahram Salek-Ardakani held the position of Senior Director-Cancer Immunology at Pfizer Inc. He also worked as an Associate Professor at the University of Florida College of Medicine.
Currently, he is serving as the Chief Scientific Officer at Janux Therapeutics, Inc. from 2021 to 2023.
Former positions of Shahram Salek-Ardakani
| Companies | Position | End |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/10/2023 |
| University of Florida College of Medicine | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| JANUX THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Shahram Salek-Ardakani
